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Background

Results

● Cancer arises when mutated cells become unresponsive to cell
cycle signaling that regulates cell growth. These uncontrolled cells
can invade and spread to other parts of the body.3
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● Due to estrogen signaling, MDSC are able to proliferate and reduce
T cell response.1
● Studies have shown phytoestrogens, specifically Lycopene and
Trans-Resveratrol, have chemopreventive potential.2
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Figure 3: MHC II and CD80 expression on cells incubated with
phytoestrogen compounds lycopene and trans-resveratrol. Compounds
mean fluorescence intensity was analyzed using flow cytometry. Anti-MHC II and
anti-CD80 antibodies bound to MHC II and CD80 respectively to measure the
amount of each receptor present in the incubated samples.
*Indicates a statistical significance, p< 0.05, when compared to MHC II and CD80
expression in estrogen.

Figure 4: Average T-cell proliferation in the presence of lyocpene
and trans-resveratrol.
The optical density of T-cells in each
compound was measured using MTT assay. T cell proliferation was
significantly decreased in the presence of estrogen.
*indicates statistically significant difference, p<0.05, of the T cell
proliferation in media and estrogen compared to lycopene and Transresveratrol.
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Figure 2: Chemical Structures of (A) Estrogen,
(B) Trans-Resveratrol, and (C) Lycopene
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Figure 1: Imaging depitcing MDSC blocking many of the
body’s defense-killing tumor cells
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● As the cancerous cells spread, Myeloid-derived suppressor cells
(MDSC) are formed and can prevent our body’s defense
mechanisms from limiting the spread of cancer.2,4
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Research Question: We will investigate the role these phytoestrogens play in reducing
estrogen from binding to myeloid precursor cells and the role they play in decreasing tumor
growth.
Hypothesis: We hypothesize that Lycopene and Trans-Resveratrol will bind to the estrogen
receptors and block all estrogenic activity, decreasing the production of MDSC cells.

Methods
Cultured

Bone marrow derived dendritic cells were incubated with
media, estrogen, trans-resveratrol, and lycopene for 24
hours.

Flow Cytometry

Fluorescent monoclonal anti-CD80-FITC and anti-MHC IIPE antibodies.
Cells were run on Accuri C6 Flow Cytometer.

T-cell Isolation and
Cell Culture

Isolated splenic CD4 T cells were cultured with bone-marrow
derived dendritic cells and compounds for seven days. Three
replicates were done for each compound.

T-cell Proliferation

ELISA T-cell
Cytokines

MTT assay used to measure the viable T cells
in culture.

IFN-γ and IL-4 specific antibodies to analyze
the amount of cytokine produced by the CD4
T-cells cultured with compounds.
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Figure 5: Average IL-4 cytokine production measured in CD4 T cells
cultured with lycopene and trans-resveratrol. CD4 T cell IL-4 production was
measured using IL-4 specific antibodies in ELISA. CD4 T cells in Transresveratrol and lycopene had diminutive IL-4 production, whereas in estrogen,
CD4 T cells produced 500 pg/ml of the cytokine.
*indicates statistically significant difference, p< 0.05, of the amount of IL-4
produced in lycopene and trans-resveratrol compared to estrogen and media.
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Figure 6: Average IFN-γ cytokine production measured in T cells
cultured with lycopene and trans-resveratrol. CD4 T cell IFN-γ
production was measured using IFN-γ specific antibodies in ELISA.
IFN-γ production was significantly higher in CD4 T cells in transresveratrol and lycopene when compared to estrogen and media.
*Indicates statistically significant differences, p< 0.05, in IFN-γ cytokine
production when compared to the IFN-γ production of CD4 T cells in
estrogen and media.

Conclusion
● T-cell proliferation significantly increased in the presence of these phytoestrogens suggesting that
lycopene and trans-resveratrol can increase the body’s defense mechanisms in combating tumor growth
by decreasing MDSCs affect on T cells.
● IL-4 is a cytokine that promotes tumor growth. IL-4 was significantly higher in the presence of estrogen
compared to these two phytoestrogens. This suggests the decrease of T-cell proliferation (Fig. 3) was
caused by estrogen.

● IFNγ increases T-cell activation which decreases tumor growth. In the presence of trans-resveratrol and
lycopene, IFNγ was significantly higher than estrogen. This provides evidence that these phytoestrogens
can bind to estrogen receptors and in turn decrease estrogenic effects on MDSCs.

Future Direction
● Investigate other phytoestrogens and introduce them to those genetically predisposed for cancer.
● Examine other cells that aid in the growth of cancerous tumors and observe different cytokines,
chemokines, and signals produced.
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